These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 9864663)

  • 1. An endothelin-transforming growth factor beta pathway in the nephrotoxicity of immunosuppressive drugs.
    Hutchinson IV
    Curr Opin Nephrol Hypertens; 1998 Nov; 7(6):665-71. PubMed ID: 9864663
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vascular endothelin, TGF-beta, and PDGF expression in FK506 nephrotoxicity of rats.
    Jeong HJ; Kim YS; Hong IC
    Transplant Proc; 1998 Nov; 30(7):3596-7. PubMed ID: 9838576
    [No Abstract]   [Full Text] [Related]  

  • 3. Individual or combined effects of enalapril and verapamil on chronic cyclosporine nephrotoxicity in rats.
    Lee SK; Park JY; Yu ES; Yang WS; Kim SB; Park SK; Park JS
    J Korean Med Sci; 1999 Dec; 14(6):653-8. PubMed ID: 10642944
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Posttransplant diastolic hypertension: associations with intragraft transforming growth factor-beta, endothelin, and renin transcription.
    Kirk AD; Jacobson LM; Heisey DM; Fass NA; Sollinger HW; Pirsch JD
    Transplantation; 1997 Dec; 64(12):1716-20. PubMed ID: 9422408
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of TGF-beta and fibrogenic genes in transplant recipients with tacrolimus and cyclosporine nephrotoxicity.
    Khanna A; Plummer M; Bromberek C; Bresnahan B; Hariharan S
    Kidney Int; 2002 Dec; 62(6):2257-63. PubMed ID: 12427154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of intrarenal endothelin 1, endothelin 3, and angiotensin II expression in chronic cyclosporin A nephrotoxicity in rats.
    Ramírez C; Olmo A; O'Valle F; Masseroli M; Aguilar M; Gómez-Morales M; Revelles F; García-Chicano MJ; Arrebola F; Reguero ME; del Moral RG
    Exp Nephrol; 2000; 8(3):161-72. PubMed ID: 10810233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclosporin induces renal proto-oncogene RNA message and increased transforming growth factor-beta prior to renal fibrosis: Modification by calcium channel blockade in the salt replete rat.
    Saggi SJ; Andoh TF; Safirstein R; Bennett WM
    Nephrology (Carlton); 2004 Apr; 9(2):58-64. PubMed ID: 15056263
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative effects of cyclosporine A and FK-506 on endothelin secretion by a cultured renal cell line, LLC-PK1.
    Nakahama H; Fukunaga M; Kakihara M; Horio M; Fujiwara Y; Fukuhara Y; Ueda N; Orita Y; Kamada T
    J Cardiovasc Pharmacol; 1991; 17 Suppl 7():S172-3. PubMed ID: 1725322
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transforming growth factor-beta1 and tumor growth factor-beta-inducible gene-H3 in nonrenal transplant cyclosporine nephropathy.
    Langham RG; Egan MK; Dowling JP; Gilbert RE; Thomson NM
    Transplantation; 2001 Dec; 72(11):1826-9. PubMed ID: 11740395
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The protective effect of neutralizing high-mobility group box1 against chronic cyclosporine nephrotoxicity in mice.
    Park HS; Kim EN; Kim MY; Lim JH; Kim HW; Park CW; Yang CW; Jin DC; Choi BS
    Transpl Immunol; 2016 Feb; 34():42-9. PubMed ID: 26603313
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polymerized type I collagen reduces chronic cyclosporine nephrotoxicity.
    Sánchez-Pozos K; Lee-Montiel F; Pérez-Villalva R; Uribe N; Gamba G; Bazan-Perkins B; Bobadilla NA
    Nephrol Dial Transplant; 2010 Jul; 25(7):2150-8. PubMed ID: 20139407
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cellular mechanisms of cyclosporine A-associated side-effects: role of endothelin.
    Meyer-Lehnert H; Bokemeyer D; Friedrichs U; Bäcker A; Kramer HJ
    Kidney Int Suppl; 1997 Oct; 61():S27-31. PubMed ID: 9328959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of cyclosporin A on the synthesis, excretion, and metabolism of endothelin in the rat.
    Abassi ZA; Pieruzzi F; Nakhoul F; Keiser HR
    Hypertension; 1996 May; 27(5):1140-8. PubMed ID: 8621208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sirolimus increases transforming growth factor-beta1 expression and potentiates chronic cyclosporine nephrotoxicity.
    Shihab FS; Bennett WM; Yi H; Choi SO; Andoh TF
    Kidney Int; 2004 Apr; 65(4):1262-71. PubMed ID: 15086465
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of hypomagnesemia in chronic cyclosporine nephropathy.
    Miura K; Nakatani T; Asai T; Yamanaka S; Tamada S; Tashiro K; Kim S; Okamura M; Iwao H
    Transplantation; 2002 Feb; 73(3):340-7. PubMed ID: 11884928
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-transforming growth factor antibody at low but not high doses limits cyclosporine-mediated nephrotoxicity without altering rat cardiac allograft survival: potential of therapeutic applications.
    Khanna AK; Plummer MS; Hilton G; Pieper GM; Ledbetter S
    Circulation; 2004 Dec; 110(25):3822-9. PubMed ID: 15583082
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transforming growth factor-beta and the dark side of cyclosporine.
    Jones NL; Durno CA
    J Pediatr Gastroenterol Nutr; 1999 May; 28(5):460-1. PubMed ID: 10328118
    [No Abstract]   [Full Text] [Related]  

  • 18. Cyclosporine withdrawal and mycophenolate mofetil treatment effects on the progression of chronic cyclosporine nephrotoxicity.
    Yang CW; Ahn HJ; Kim WY; Li C; Kim HW; Choi BS; Cha JH; Kim YS; Kim J; Bang BK
    Kidney Int; 2002 Jul; 62(1):20-30. PubMed ID: 12081560
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Celecoxib offsets the negative renal influences of cyclosporine via modulation of the TGF-β1/IL-2/COX-2/endothelin ET(B) receptor cascade.
    El-Gowelli HM; Helmy MW; Ali RM; El-Mas MM
    Toxicol Appl Pharmacol; 2014 Mar; 275(2):88-95. PubMed ID: 24462674
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Mediators involved in the nephrotoxicity of cyclosporin A].
    Simon N; Barré J; Jolliet P; Urien S; Tillement JP
    Therapie; 1997; 52(4):329-33. PubMed ID: 9437887
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.